Noni warning letter
This article was originally published in The Tan Sheet
Executive Summary
Claims that Noni Juice Liquid Herbal Supplement and Noni Extra Strength Cleansing Formula AM/PM treat diabetes, asthma, cataracts, high blood pressure, breast cancer, depression and migraine render the products unapproved new drugs, FDA tells Carolina, Puerto Rico-based Mundo Natural in an April 29 warning letter. Similar claims about relief of arthritis, headaches and the immune system made for other noni juice products earned warning letters for three different companies in 2002 (1"The Tan Sheet" July 15, 2002, p. 9)...
You may also be interested in...
FDA Warning Letters Increasingly Targeting Internet Claims
More than 80% of the warning letters concerning OTC drug and dietary supplement products sent in the last few months have focused on Internet claims
Device Week, 05 March - Remote Monitoring Reimbursement, T-cell Diagnostics And A Digital Health Feature
In this week's podcast, managing editor Marion Webb discusses a new monthly digital health roundup which will soon feature on Medtech Insight. Managing editor Reed Miller discusses reimbursement difficulties as it applies to remote cardiac monitoring. UK-based reporter Barnaby Pickering gives an overview of an interview with the chief medical officer of Adaptive Biotechnologies about its new T-Detect platform.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: